Dr. Bernard R. Chinnasami, MD

Dr. Chinnasami practices at High Point Behavioral Health in High Point, North Carolina.

Dr. Chinnasami's NPI, 1821017021, was assigned on July 19, 2006. Dr. Chinnasami graduated from Ohio State University College of Homeopathic Medicine in 1987. Dr. Chinnasami holds North Carolina license 35863.

Dr. Chinnasami's primary practice is High Point Behavioral Health, at 601 North Elm Street, High Point, NC 27261. The practice phone is (800) 525-9375.

Dr. Chinnasami's primary practice is High Point Behavioral Health in High Point, North Carolina. Dr. Chinnasami is also affiliated with High Point Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Chinnasami to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chinnasami practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chinnasami's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chinnasami is licensed in North Carolina.

CMS data shows 435 Medicare services from Dr. Chinnasami across 3 procedure codes in 2024, all of them office visits, for 155 Medicare patients. Medicare paid $35,064 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Chinnasami in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chinnasami's median patient age at 74, with 62% women.

In 2024, Dr. Chinnasami wrote 1,574 Medicare Part D claims for 241 patients. 70% of them were for generic drugs. CMS names the drug for 1,366 of them, across 37 drugs with 11 or more claims each, at $3,140,706 in total drug cost. In 2023, CMS named 1,116 claims across 28 drugs.

Dr. Chinnasami accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 94 general payments to Dr. Chinnasami from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Celgene Corporation paid the most, $302.

Dr. Chinnasami graduated from Ohio State University College of Homeopathic Medicine in 1987.